Barely Significant
← all excerpts

Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria.

J Asthma Allergy · 2026 · PMC12911961 · PMID 41710136

Europe PMCDOI
1
hedged sentence
0.0300
closest p · 0.6× alpha
0.0300
boldest claim

The sentences

did not reach statistical significancep = 0.03actually significant
After one year of treatment, patients with EGPA showed numerically higher rates of good or complete response and clinical remission compared with patients with severe asthma; however, these differences did not reach statistical significance (70% vs 55.7% and 30% vs 18.5%, respectively; p = 0.03).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.